151 related articles for article (PubMed ID: 16149610)
21. [The expression of NCC-ST-439, a tumor marker, in human breast cancer patients].
Miyahara E; Toi M; Wada T; Yamada H; Osaki A; Yanagawa E; Toge T
Gan No Rinsho; 1990 Sep; 36(11):2023-6. PubMed ID: 2232168
[TBL] [Abstract][Full Text] [Related]
22. [Fundamental and clinical evaluation of immunoradiometric assay (IRMA) for serum pancreatic oncofetal antigen (POA)].
Ohba N; Hashimoto T; Nishibu M; Kashiwaya Y; Kawai K; Matsubara F; Miyazaki I
Rinsho Byori; 1989 Feb; 37(2):153-8. PubMed ID: 2733181
[No Abstract] [Full Text] [Related]
23. CAM 26 and CAM 29: methodological evaluations and first clinical employment in breast cancer.
Priolo G; Pecchio F; Rapellino M; Aimo G; Spertino F; Pepe C
J Nucl Med Allied Sci; 1990; 34(4 Suppl):21-3. PubMed ID: 2092121
[No Abstract] [Full Text] [Related]
24. [CA125].
Kuzuya K; Kuwabara M; Ariyoshi Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():637-41. PubMed ID: 16149599
[No Abstract] [Full Text] [Related]
25. [Gamma-seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
[No Abstract] [Full Text] [Related]
26. [Basic fetoprotein (BFP)].
Ishii M; Seino Y
Nihon Rinsho; 2005 Aug; 63 Suppl 8():629-31. PubMed ID: 16149596
[No Abstract] [Full Text] [Related]
27. [Squamous cell carcinoma antigen].
Nawata S; Sugino N; Kato H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():684-6. PubMed ID: 16149611
[No Abstract] [Full Text] [Related]
28. [Clinical significance of carbohydrate antigen 19-9 assay as a tumor marker].
Ohkura H; Sakawaki T; Hara K; Mitsuhashi F
Nihon Rinsho; 1990 Feb; 48 Suppl():931-3. PubMed ID: 2192177
[No Abstract] [Full Text] [Related]
29. [Serum level of tumor markers (antigen Ca 19-9, CEA, ferritin) in digestive tumors. Their diagnostic usefulness].
Jovin G; Stănel I; Popovici I; Oproiu A
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1988; 40(3):223-9. PubMed ID: 2904162
[No Abstract] [Full Text] [Related]
30. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
Huang C; Bei L; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of serum CA 19-9 determination in digestive tract cancer].
Chen SB
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):58-60. PubMed ID: 2364873
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of 2-6 sialyl Le(a) antigen assay as a tumor marker].
Kannagi R; Itai S; Harada R
Nihon Rinsho; 1990 Feb; 48 Suppl():1045-52. PubMed ID: 2355503
[No Abstract] [Full Text] [Related]
33. [The existence of a correlation between the serum values of MCA and CA 15.3 in patients with digestive tumors].
Roiz MC; Vizoso F; Allende MT; Ruibal A
Rev Clin Esp; 1990 Nov; 187(7):376. PubMed ID: 2091127
[No Abstract] [Full Text] [Related]
34. [Immunosuppressive acid protein (IAP)].
Ikeda H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():711-2. PubMed ID: 16149619
[No Abstract] [Full Text] [Related]
35. [NCC-ST-439].
Sugano K
Nihon Rinsho; 1999 Dec; 57 Suppl():506-8. PubMed ID: 10778175
[No Abstract] [Full Text] [Related]
36. [NCC-ST-439].
Sugano K
Nihon Rinsho; 2010 Jul; 68 Suppl 7():726-8. PubMed ID: 20960857
[No Abstract] [Full Text] [Related]
37. [Clinical significance of Span-1 antigen assay as a tumor marker].
Satake K; Chung YS; Umeyama K
Nihon Rinsho; 1990 Feb; 48 Suppl():1053-6. PubMed ID: 2355504
[No Abstract] [Full Text] [Related]
38. [Study on the clinical usefulness of NCC-ST-439 in breast cancer].
Takahashi H; Nakanishi K; Taguchi K; Hasumi T; Hamada H; Sasaki F; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1991 Feb; 18(2):245-9. PubMed ID: 1992918
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
[TBL] [Abstract][Full Text] [Related]
40. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2085-93. PubMed ID: 1417016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
